Gerald H. Sokol

Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ.

American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021.

Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015.

Florida Cancer Specialists PL provides health care services. It services include clinical trials, diagnostic imaging, oncology program, pathology lab, nursing, and related services. The company was founded by William N. Harwin in 1984 and is headquartered in Fort Myers, FL.

Florida Health Sciences Center, Inc. provides medical and health care services. Its services include bloodless medicine and surgery, burn, cancer, ear, nose, throat, emergency and trauma and endocrinology and neurology. The company was founded in 1971 and is headquartered in Tampa, FL.